Filter
1

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

for
Lung Cancer, Small Cell Lung Carcinoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05620342

Early_phase1, Recruiting

Dabrafenib and/or Trametinib Rollover Study

for
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers,
Location: Toronto
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT03340506

Recruiting

Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)

for
Untreated Advanced Non-Small Cell Lung Cancer
Location: Voorhees NJ
Sponsor: The Cooper Health System

Sex: All

Age: 18+

Code: NCT00254319

Phase2, Recruiting

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

for
Non-Small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT01639508

Phase2, Recruiting

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: New York City NY, Louisville KY, Nashville TN, Omaha NE,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06046495

Phase1, Recruiting

Interested in new non small cell lung cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Bronx NY, Durham NC, Chattanooga TN, Nashville TN,
Sponsor: Agennix

Sex: All

Age: 18+

Code: NCT00706862

Phase3, Recruiting

A Study Evaluating MM-310 in Patients With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma,
Location: Durham NC, Buffalo NY, Rochester MN, Scottsdale AZ,
Sponsor: Merrimack Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03076372

Phase1, Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Boston MA, Miami FL, Denver CO, Nashville TN,
Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All

Age: 18+

Code: NCT06239194

Phase1, Phase2, Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

for
Solid Tumor, Renal Cell Cancer Metastatic,
Location: Philadelphia PA, Dallas TX
Sponsor: Eutilex

Sex: All

Age: 18+

Code: NCT04903873

Phase1, Phase2, Recruiting

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer
Location: Ohio City OH
Sponsor: Chong Kun Dang Pharmaceutical

Sex: All

Age: 19+

Code: NCT07439094

Phase1, Phase2, Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07261631

Phase1, Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07468071

Phase1, Phase2, Recruiting

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Fairfax VA
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT07538804

Phase1, Phase2, Recruiting

HEARTS Trial for Thoracic Cancers

for
Non-Small Cell Lung Cancer (Stage III),
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT07132918

Phase2, Recruiting

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC,
Location: Fairfax VA, Tampa FL, Farmington Hills MI,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07085091

Phase1, Recruiting

ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06902272

Phase2, Recruiting

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

for
Non-Small Cell Lung Cancer
Location: Boston MA, Stuart FL, Birmingham AL, Nashville TN
Sponsor: Precision Therapeutics

Sex: All

Age: 18+

Code: NCT01450553

Recruiting

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

for
Non Small Cell Lung Cancer
Location: Camden NJ
Sponsor: The Cooper Health System

Sex: All

Age: 18+

Code: NCT02568033

Early_phase1, Recruiting

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

for
Non Small Cell Lung Cancer
Location: Tampa FL, Saint Petersburg FL, Madison WI, Houston TX
Sponsor: Innate Pharma

Sex: All

Age: 18+

Code: NCT05742607

Phase2, Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Lake Success NY, Grand Rapids MI, Houston TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06242470

Phase1, Recruiting